Latest news with #AtlasEnergyCorp
Cision Canada
7 days ago
- Business
- Cision Canada
ACQUISITION OF COMMON SHARES AND WARRANTS OF ATLAS ENERGY CORP. BY MARK HODGSON
CALGARY, AB, July 7, 2025 /CNW/ - Pursuant to the early warning requirements of applicable Canadian securities laws, Mark Hodgson (" Acquiror") reports that, on June 19, 2025, the Acquiror, together with joint actors, acquired an aggregate of 80,000,000 common shares (" Common Shares") in the capital of Atlas Energy Corp. (" Atlas" or the " Company") and 80,000,000 Common Share purchase warrants (" Warrants") for a total purchase price of $4.0 million under a non-brokered private placement of 300,000,000 Common Shares and 300,000,000 units (" Units") of the Company at a price of CDN$0.05 per Common Share and Unit, as applicable (the " Private Placement"). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of CDN$0.05 (the " Exercise Price") per Common Share at any time prior to June 19, 2025. The Warrants will vest and become exercisable as to one-third upon the 10-day weighted average trading price of the Common Shares (the " Market Price") equaling or exceeding 50% above the Exercise Price, an additional one-third upon the Market Price equaling or exceeding 75% above the Exercise Price and a final one-third upon the Market Price equaling or exceeding 100% above the Exercise Price. Concurrent with the Private Placement, the Company: (a) changed its name to "Atlas Energy Corp." from "Willow Biosciences Inc."; (b) consolidated its Common Shares on the basis of one (1) post-consolidation Common Share for every five (5) pre-consolidation Common Shares (the " Consolidation"); (c) appointed a new management team (the " New Executive Team") led by Mark Hodgson as President and Chief Executive Officer, Travis Doupe as Chief Financial Officer, Don Kornelsen as Vice President, Commercial, Ryan Giroux as Vice President, Corporate Development and Blair Anderson as Vice President, Geoscience of the Company and Richard Naden as a Senior Executive; and (d) reconstituted its board of directors, with the new board being comprised of Mark Hodgson, Richard F. McHardy, Gary Brown, Glenn McNamara and Scott Price. For the purposes of this Press Release, all figures are presented on a post-Consolidation basis. The New Executive Team will focus on investing in producing and growth-oriented oil and gas assets aligned with their prior operating expertise. With a disciplined and diversified strategy, the Company will aim to acquire economic interests in undercapitalized assets that have been overlooked amid recent shifts in capital allocation within the industry. The portfolio will be structured to manage risk and capture upside by balancing exposure across jurisdictions, asset stages, commodity price dynamics and offtake structures. The Company is uniquely positioned as one of the only royalty and streaming platforms dedicated to international oil and gas - offering a rare opportunity to generate strong shareholder returns in an underserved segment of the market. Immediately following the completion of the Private Placement, Acquiror beneficially owned or controlled, directly or indirectly, 80,000,000 Common Shares and 80,000,000 Warrants pursuant to the Private Placement, representing 12.71% (on a non-diluted basis) and 22.55% (on a fully diluted basis) of the voting securities of the Company. Prior to the Private Placement, Acquiror did not hold any securities of Atlas. Acquiror acquired the Common Shares and Warrants for investment purposes and may, in the future, increase or decrease its ownership of securities of Atlas, directly or indirectly, from time to time depending upon, among other things, the business and prospects of Atlas and future market conditions. For further details regarding the acquisition of the Common Shares and Warrants described above, see the Early Warning Report dated July 4, 2025, available on the Company's SEDAR+ profile. SOURCE Mark Hodgson
Cision Canada
19-06-2025
- Business
- Cision Canada
WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF TRANSFORMATIVE RECAPITALIZATION TRANSACTIONS TO FORM ATLAS ENERGY CORP.
CALGARY, AB, June 19, 2025 /CNW/ - Atlas Energy Corp. (formerly Willow Biosciences Inc.) (the " Company") (TSX: WLLW), in connection with its TSXV Sandbox listing, is pleased to announce that it has completed its previously announced: (a) non-brokered equity private placement for aggregate gross proceeds of $30.0 million (the " Private Placement"); (b) appointment of a new management team and new board of directors; (c) name change to "Atlas Energy Corp." (the " Name Change"); and (d) consolidation (the " Consolidation") of the common shares of the Company (the " Common Shares") on the basis of one (1) post-Consolidation Common Share for every five (5) pre-Consolidation Common Shares. The post-Consolidation Common Shares will commence trading on the facilities of the Toronto Stock Exchange (the " TSX") under the new name "Atlas Energy Corp." and new symbol "ATLE" within 2 business days of TSX receipt and acceptance of the required documentation pertaining to the Name Change and Consolidation, which is expected to be on or about market opening on Monday, June 23, 2025. The post-Consolidation Common Shares are expected to be delisted from the TSX on or about market close on Monday, June 23, 2025 and to commence trading under the new name "Atlas Energy Corp." and new symbol "ATLE" on the facilities of the TSX Venture Exchange (the " TSXV") at market opening on Tuesday, June 24, 2025. "Listing Atlas Energy Corp marks a major milestone in our mission to redefine capital access for international energy producers. With $30 million now raised and a strong shareholder base behind us, we're actively evaluating a range of high-quality royalty and streaming opportunities across the globe," said Mark Hodgson, the Company's President and Chief Executive Officer. "This is just the beginning — we're building a new kind of energy partner: one that delivers flexible, non-dilutive capital to responsible operators in the world's most dynamic basins." Pursuant to the Private Placement, on a post-Consolidation basis, the Company issued an aggregate of 300.0 million units (" Units") and 300.0 million Common Shares at a price of $0.05 per Unit and Common Share, as applicable, for gross proceeds of $30.0 million. Proceeds from the Private Placement will be used to fund future acquisition opportunities and for general working capital purposes. Each Unit issued under the Private Placement was comprised of one Common Share and one Common Share purchase warrant (each, a " Warrant"). Each Warrant will entitle the holder thereof to purchase one (1) Common Share at a price of $0.05 (the " Exercise Price") until June 19, 2030. The Warrants will vest and become exercisable in accordance with the terms set forth in the press release of the Company dated May 7, 2025. Pursuant to applicable securities laws, all securities issued pursuant to the Private Placement are subject to a hold period of four months plus one day following the date of issuance of such securities. The Private Placement remains subject to the final approval of the TSXV. Following the Private Placement and the Consolidation, there are a total of 629,439,353 issued and outstanding Common Shares. New Management Team and New Board The new management team and new board were appointed concurrently with the completion of the Private Placement, led by Mark Hodgson as President and Chief Executive Officer, Travis Doupe as Chief Financial Officer, Don Kornelsen as Vice President, Commercial, Ryan Giroux as Vice President, Corporate Development and Blair Anderson as Vice President, Geoscience of the Company and Richard Naden as a Senior Executive and including Mark Hodgson, Richard F. McHardy, Gary Brown, Glenn McNamara and Scott Price as directors. In addition, Sanjib (Sony) Gill, a partner in the Calgary office of the national law firm Stikeman Elliott LLP, will act as Corporate Secretary. The new management team expects to focus on investing in producing and growth-oriented oil and gas assets aligned with their prior operating expertise. With a disciplined and diversified strategy, the Company will aim to acquire economic interests in undercapitalized assets that have been overlooked amid recent shifts in capital allocation within the industry. The new management team is actively evaluating numerous opportunities. Transition to TSXV Sandbox Program and Voluntary Delisting from TSX As previously announced, the Company has received conditional approval to list its Common Shares on the facilities of the TSXV as a Tier 2 Investment Issuer under the TSXV Sandbox Program. The TSXV Sandbox is an initiative intended to facilitate listing applications that may not generally satisfy the requirements and guidelines of the TSXV, but due to facts or situations unique to a particular issuer otherwise warrant a listing on the TSXV or an exemption from certain requirements in the TSXV Corporate Finance Manual. The Company does not currently meet certain of the original listing requirements of the TSXV set out in Policy 2.1 – Initial Listing Requirements because the Company will have no specific investments at the time of listing on TSXV and will therefore not meet the initial listing requirement of having 50% of its available funds invested in 2 specific investments at the time of listing to meet initial listing requirements for a Tier 2 Investment Issuer. As such, the TSXV has exercised its discretion to waive certain original listing requirements in granting the Company conditional approval for listing pursuant to the TSXV Sandbox. The Company's press release dated June 16, 2025 provides an overview of all waivers granted in connection with the Company's listing, details on the listing conditions imposed by the Company, the exit conditions the Company must meet in order to exit TSXV Sandbox, and any consequences if the Company does not meet these exit conditions. Once listed, there can be no assurance that the Company will meet all the exit conditions. Additional Information for Willow Shareholders The Name Change and the Consolidation have not affected the validity of previously issued share certificates of the Company. However, registered shareholders are required to exchange their share certificates for share certificates evidencing the post-Name Change and post-Consolidation Common Share amount. Registered shareholders have been mailed a letter of transmittal today containing instructions on how to surrender share certificates evidencing the pre-Consolidation Common Share amount to Odyssey Trust Company (the " Depositary"). A sample letter of transmittal is also available on the Company's profile on if a registered shareholder does not receive a letter of transmittal in respect of its Common Shares represented by share certificates. The Depositary will forward to each registered shareholder who has sent the required documents set forth in the letter of transmittal new share certificates evidencing the new post-Name Change and post-Consolidation Common Share amount. Until surrendered, each share certificate representing pre-Consolidation Common Shares will be deemed for all purposes to represent the post-Consolidation Common Shares to which the holder is entitled following the Consolidation. Non-registered shareholders (eg. beneficial shareholders holding Common Shares through an intermediary (a securities broker, dealer, bank or financial institution)) should be aware that the intermediary may have different procedures for processing the Consolidation than those that will be put in place by the Company for registered shareholders. If shareholders hold their Common Shares through an intermediary and they have questions in this regard, they are encouraged to contact their intermediaries. No fractional shares have been issued pursuant to the Consolidation. Any fractional interest in Common Shares that is less than 0.5 resulting from the Consolidation has been rounded down to the nearest whole Common Share and any fractional interest in Common Shares that is 0.5 or greater has been rounded up to the nearest whole Common Share. The Company's new CUSIP number is 048924104 and new ISIN number is CA0489241046. The Company's outstanding Common Share purchase warrants have been adjusted on the same basis as the Consolidation with respect to the underlying Common Shares exercisable pursuant to the warrants with proportionate adjustments being made to exercise prices. National Bank Financial Inc. and DeltaCap Partners Inc. were engaged as financial advisors in connection with the Private Placement and received cash advisory fees in the aggregate amount of $750,000. About Atlas Energy Corp. The recapitalized Company is an international upstream royalty and streaming company focused on the identification, acquisition, management and monetization of a well-diversified portfolio of international upstream oil and gas royalty and streaming transactions. The Company will also evaluate royalty and streaming opportunities in the North American market should such opportunities become available at similar attractive metrics. Reader Advisories Investors are cautioned that, except as disclosed in the Company's TSXV Form 2B – Listing Application dated June 17, 2025, which was prepared and filed in connection with the recapitalization transactions, as available on the Company's profile on any information released or received with respect to the recapitalization transactions may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative. The TSX Venture Exchange has in no way passed upon the merits of the recapitalization transactions and has neither approved nor disapproved of the contents of this press release. Investors are advised that the Company is expected to be listed on TSXV as a TSXV Sandbox Listing as the Company will not meet all TSXV's listing requirements at the time of listing. Investors are advised to review the Company's news release dated June 16, 2025 to review all waivers granted in connection with the Company's listing, details on the listing conditions imposed by the Company, the exit conditions the Company must meet in order to exit TSXV Sandbox, and any consequences if the Company does not meet these exit conditions. Once listed, there can be no assurance that the Company will meet all the exit conditions. For details on TSXV Sandbox Listings, please visit resources/tsxv-sandbox. Forward-Looking and Cautionary Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. More particularly and without limitation, this news release contains forward-looking statements and information concerning: the use of proceeds from the Private Placement; final approval of the TSXV in respect of the listing of the Common Shares on the facilities of the TSXV; the business plan of the Company; and the Company's ability to meet the exit conditions. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company, including expectations and assumptions concerning TSXV and regulatory approvals, the use of proceeds from the Private Placement and the ability of the new management team to implement the corporate strategy of the recapitalized company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. These risks and uncertainties, include, but are not limited to, the parties being unable to obtain the required TSXV approvals, fluctuations in commodity prices, changes in industry regulations and political landscape both domestically and abroad, foreign exchange or interest rates, stock market volatility, the imposition or expansion of tariffs imposed by domestic and foreign governments or the imposition of other restrictive trade measures, retaliatory or countermeasures implemented by such governments, including the introduction of regulatory barriers to trade and the potential effect on the demand and/or market price for the oil and gas production and/or otherwise adversely affects the Company, the availability of investment opportunities meeting the new management team's investment criteria, the retention of key management and employees and obtaining required approvals of regulatory authorities. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. The Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law. All dollar figures included herein are presented in Canadian dollars, unless otherwise noted. SOURCE Willow Biosciences Inc.
Yahoo
17-06-2025
- Business
- Yahoo
WILLOW BIOSCIENCES INC. ANNOUNCES CONDITIONAL ACCEPTANCE OF TSX VENTURE EXCHANGE TO LIST PURSUANT TO THE TSXV SANDBOX
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./ CALGARY, AB, June 16, 2025 /CNW/ - Willow Biosciences Inc. (the "Company") (TSX: WLLW), in connection with its proposed TSXV Sandbox listing, is pleased to announce that it has received conditional acceptance to list its common shares on the facilities of the TSX Venture Exchange (the "TSXV") as a Tier 2 Investment Issuer under the TSXV Sandbox Program upon closing of the previously announced (a) non-brokered equity private placement for aggregate gross proceeds of $30.0 million (the "Private Placement"); (b) appointment of a new management team and new board of directors; (c) name change to "Atlas Energy Corp."; and (d) consolidation (the "Consolidation") of the common shares of the Company (the "Common Shares") on the basis of one (1) post-Consolidation Common Share for every five (5) pre-Consolidation Common Shares, which are expected to be completed on June 19, 2025 (collectively, the "Transaction"). The TSXV Sandbox is an initiative intended to facilitate listing applications that may not generally satisfy the requirements and guidelines of the TSXV, but due to facts or situations unique to a particular issuer otherwise warrant a listing on the TSXV or an exemption from certain requirements in the TSXV Corporate Finance Manual. The post-Consolidation Common Shares are expected to commence trading under the new name "Atlas Energy Corp." and new symbol "ATLE" on the facilities of the TSXV at market opening on Tuesday, June 24, 2025, and the common shares of Willow Biosciences Inc. will be concurrently delisted from the Toronto Stock Exchange (the "TSX").The Company will remain a "reporting issuer" under applicable Canadian securities laws through the listing transition process from the TSX to the TSXV. Shareholder approval is not required under the policies of the TSX to proceed with the transition as the TSXV is an acceptable alternative market. No action is required by shareholders in connection with the transition of the Company's listing to the TSXV. The Company does not currently meet certain of the continued listing requirements of the TSX or the original listing requirements of the TSXV set out in Policy 2.1 – Initial Listing Requirements because the Company will have no specific investments at the time of listing on TSXV and will therefore not meet the initial listing requirement of having 50% of its available funds invested in 2 specific investments at the time of listing to meet initial listing requirements for a Tier 2 Investment Issuer. As such, the TSXV has exercised its discretion to waive certain original listing requirements in granting the Company conditional acceptance of listing pursuant to the TSXV Sandbox. The Company will remain listed pursuant to the TSXV Sandbox until the following exit conditions (the "Exit Conditions") are met within 12 months of listing on the TSXV (the "Exit Deadline"): (i) the Company has completed the Private Placement for aggregate gross proceeds of $30.0 million; (i) the Company has deployed at least 50% of its available funds following completion of the Private Placement to fund two or more qualifying investments that are satisfactory to the TSXV; (ii) the Company has no outstanding compliance or disclosure issues; and (iii) the Company has made a formal application to the TSXV for an exit review, along with the applicable filing fee, and the TSXV is satisfied the Exit Conditions have been met. If the Company has not satisfied the Exit Conditions by the Exit Deadline, the Company's listing may be transferred from the TSXV to the NEX. So long as the Company remains a TSXV Sandbox issuer, it will also be subject to the following restrictions and disclosure obligations in addition to the TSXV tier 2 continued listing requirements and disclosure obligations pursuant to the policies of the TSXV: (a) any proposed investment is subject to TSXV review and acceptance, including all investments that would otherwise be considered an "Exempt Transaction" as such term is defined in Policy 5.3 – Acquisitions and Dispositions; (b) all the Common Shares and Common Share purchase warrants to be issued to the new management team and new board pursuant to the Private Placement will be held in escrow pursuant to an escrow agreement in the form of TSXV's Form 5D. The first release from escrow will occur on the date on which the TSXV issues a bulletin confirming the Company has satisfied all the Exit Conditions and accepted the Company's exit from the TSXV Sandbox program (the "Exit Date"). On the Exit Date, upon the Company meeting all TSXV Sandbox listing requirements, the TSXV's Tier 2 escrow release schedule will be retroactively applied to the original listing date of the Company on the TSXV pursuant to the TSXV Sandbox program; (c) the Company may grant equity incentive awards but no such awards may vest, be settled or be exercised, as the case may be, until the Exit Date, or in the case of restricted share units, deferred share units or performance share units, until the later of (i) one year from the date of grant and (ii) the Exit Date; and (d) all continuous disclosure documents of the Company must refer to the Company being listed on the TSXV under the TSXV Sandbox program. The Company has received a waiver from the sponsorship requirements under Policy 2.2 – Sponsorship and Sponsorship Requirements of the TSXV of the TSXV's Corporate Finance Manual. The Company also announces the voting results from its special meeting of shareholders held on June 16, 2025 (the "Meeting"). A total of 55,889,478 Common Shares, representing approximately 37.97% of the Company's issued and outstanding shares were represented at the meeting. The shareholders approved the below matters. The resolutions approving the below matters may be viewed in full in the Company's management information circular dated May 13, For# % Reduction of Stated Capital. Special resolution authorizing and approving, at the sole discretion of the Company's board of directors, a reduction in statedcapital of the capital account maintained by the Company in respect of its Common Shares 48,109,399 99.46 % Initial Share Consolidation. Special resolution authorizing and approving, at the sole discretion of the Company's board of directors, the initial Consolidation of the Common Shares on the basis of one (1) post-Consolidation Common Sharefor every five (5) pre-Consolidation Common Shares to be effected pursuant to the Transaction 53,991,264 96.61 % Further Share Consolidation. Special resolution authorizing and approving, at the sole discretion of the Company's board of directors, a further consolidation of the Common Shares on the basis of a consolidation ratio of up to forty (40) pre-consolidationCommon Shares for each post-consolidation Common Share, such further share consolidation to be effected anytime prior to the Company's next annual meeting of shareholders 53,607,577 95.92 % For complete voting results on all matters approved at the Meeting, please see the Company's Report of Voting Results dated June 16, 2025, available on SEDAR+ at The Company Following completion of the Transaction, the recapitalized Company will be an international upstream royalty and streaming company focused on the identification, acquisition, management and monetization of a well-diversified portfolio of international upstream oil and gas royalty and streaming transactions. The Company will also evaluate royalty and streaming opportunities in the North American market should such opportunities become available at similar attractive metrics. Reader Advisories Completion of the Transaction is subject to a number of conditions, including but not limited to, the final acceptance of the TSXV. There can be no assurance that the Transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in a TSXV Form 2B – Listing Application to be prepared and filed in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative. This press release is not an offer of the securities for sale in the United States. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The TSX Venture Exchange has in no way passed upon the merits of the Transaction and has neither approved nor disapproved of the contents of this press release. Investors are advised that the Company is expected to be listed on TSXV as a TSXV Sandbox Listing as the Company will not meet all TSXV's listing requirements at the time of listing. Investors are advised to review this news release to review all waivers granted in connection with the Company's listing, details on the listing conditions imposed by the Company, the exit conditions the Company must meet in order to exit TSXV Sandbox, and any consequences if the Company does not meet these exit conditions. Once listed, there can be no assurance that the Company will meet all the Exit Conditions. For details on TSXV Sandbox Listings, please visit resources/tsxv-sandbox. Forward-Looking and Cautionary Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. More particularly and without limitation, this news release contains forward looking statements and information concerning: the Transaction; the timing and ability of the Company to commence trading on the TSXV (if at all); and the business and operations of the Company; the completion, ratio and timing of the Consolidation; the recapitalized Company's corporate strategy; the financial performance of the recapitalized Company; and other anticipated benefits of the Transaction. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company, including expectations and assumptions concerning the Transaction, the Consolidation, the satisfaction of other closing conditions in accordance with the terms of the Agreement and the ability of the new management team to implement the corporate strategy of the recapitalized Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward looking statements and information because the Company can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. These risks and uncertainties, include, but are not limited to, fluctuations in commodity prices, changes in industry regulations and political landscape both domestically and abroad, foreign exchange or interest rates, stock market volatility, the imposition or expansion of tariffs imposed by domestic and foreign governments or the imposition of other restrictive trade measures, retaliatory or countermeasures implemented by such governments, including the introduction of regulatory barriers to trade and the potential effect on the demand and/or market price for the oil and gas production and/or otherwise adversely affects the Company, the availability of investment opportunities meeting the new management team's investment criteria, the retention of key management and employees and obtaining required approvals of regulatory authorities. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. The Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law. All dollar figures included herein are presented in Canadian dollars. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. SOURCE Willow Biosciences Inc. View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Market Online
13-05-2025
- Business
- The Market Online
Willow Biosciences reports Q1 2025 earnings on the eve of its major reorganization
Willow Biosciences (TSX:WLLW) has announced its financial results for its Q1 ended March 31, 2025, showcasing a significant turnaround in its financial performance The company reported a revenue of C$1.76 million, a substantial increase from C$0.051 million in the same period last year The company is undergoing a sweeping reorganization that includes the appointment of a new executive team and board of directors, as well as a rebranding initiative Willow Biosciences stock (TSX:WLLW) last traded at $0.03 Willow Biosciences (TSX:WLLW) has announced its financial results for its Q1 ended March 31, 2025, showcasing a significant turnaround in its financial performance. The company reported a revenue of C$1.76 million, a substantial increase from C$0.051 million in the same period last year. Net loss for the quarter was C$0.317 million, a marked improvement from the C$2.36 million loss reported a year ago. This financial news follows last week's statement of Willow's C$30 million recapitalization financing plan. The company is undergoing a sweeping reorganization that includes the appointment of a new executive team and board of directors, as well as a rebranding initiative. Willow Biosciences will soon emerge as Atlas Energy Corp. Following the reorganization, Atlas Energy will pivot its focus towards becoming an international upstream royalty and streaming company. The firm aims to build a diversified portfolio of oil and gas royalty and streaming assets, with a primary focus on international markets and selective opportunities in North America. This news caused the company's stock to rocket 200 per cent higher and it has risen 250 per cent since then. This dramatic shift comes after Willow reported a net loss of C$6.1 million in 2024 and declared it would cease active operations. The reorganization and rebranding efforts are expected to position Atlas Energy Corp. for sustainable growth and profitability in the energy sector. Willow Biosciences Inc. develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow Biosciences stock (TSX:WLLW) last traded at $0.03. Join the discussion: Find out what everybody's saying about this stock on Willow Biosciences' Bullboard, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
The Market Online
08-05-2025
- Business
- The Market Online
Willow Biosciences up 200% on news of transformation into Atlas Energy Corp.
Willow Biosciences (TSX:WLLW) unveiled a C$30 million recapitalization financing plan, alongside a sweeping reorganization that will see the company emerge as Atlas Energy Corp. Following the reorganization, Atlas Energy Corp. will pivot its focus toward becoming an international upstream royalty and streaming company Atlas will aim to build a diversified portfolio of oil and gas royalty and streaming assets, with a primary focus on international markets and selective opportunities in North America. Willow Biosciences stock (TSX:WLLW) closed 200 per cent higher on Wednesday at $0.03 Willow Biosciences (TSX:WLLW) unveiled a transformative C$30 million recapitalization financing plan, alongside a sweeping reorganization that includes a new executive team, board of directors, and a rebranding initiative that will see the company emerge as Atlas Energy Corp. The company explained in a news release that it had signed a definitive agreement with a group of initial investors—Mark Hodgson, Don Kornelsen, Ryan Giroux, Blair Anderson, and Richard Naden—who will lead the strategic shift. The recapitalization will be executed through a non-brokered private placement, raising gross proceeds of $30 million. As part of the transaction, Willow Biosciences will undergo a name change to Atlas Energy Corp., pending shareholder approval. The company also plans to consolidate its common shares on a 1-for-5 basis to meet TSX Venture Exchange listing requirements. Upon completion, the company will delist from the Toronto Stock Exchange and begin trading on the TSXV under the new ticker symbol ATLE. The new executive team will be spearheaded by: Mark Hodgson , president & CEO , president & CEO Travis Doupe , chief financial officer , chief financial officer Don Kornelsen , VP, commercial , VP, commercial Ryan Giroux , VP, corporate development , VP, corporate development Blair Anderson , VP, geoscience , VP, geoscience Richard Naden, senior executive Following the reorganization, Atlas Energy Corp. will pivot its focus toward becoming an international upstream royalty and streaming company. The firm aims to build a diversified portfolio of oil and gas royalty and streaming assets, with a primary focus on international markets and selective opportunities in North America. The transaction is expected to close around June 19, 2025, subject to regulatory and shareholder approvals. It was only back in March when Willow reported a net loss of C$6.1 million in 2024 and declared it would cease active operations. Willow Biosciences Inc. develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow Biosciences stock (TSX:WLLW) closed 200 per cent higher on Wednesday at $0.03. While it has seen 500 per cent growth in the past month, it is also 68.42 per cent lower than where it was this time last year. Join the discussion: Find out what everybody's saying about this stock on Willow Biosciences' Bullboard, and check out the rest of Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
